OneStep provides smartphone-based, FDA-listed AI motion analysis that turns phones into clinical-grade gait and mobility assessment tools. Its platform captures continuous, real-life patient movement data to give clinicians objective insights on mobility and overall health. The company positions gait as a vital sign to aid early detection of conditions such as fall risk, Parkinson’s and Alzheimer’s disease. OneStep’s technology aims to improve patient outcomes, streamline documentation, and support better clinical decision-making while reducing costs related to mobility complications. The platform also supports Remote Therapeutic Monitoring (RTM) reimbursement opportunities to generate new revenue for providers. OneStep recently raised $36M to support its growth and product development plans.

Total raised

$36M

Funding rounds

1

Latest round

Equity

Latest activity

Oct 2024